Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180273 | SCV000232673 | benign | not specified | 2015-02-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000180273 | SCV000523307 | benign | not specified | 2016-09-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000463104 | SCV000554480 | benign | Brugada syndrome 8 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621437 | SCV000736378 | benign | Cardiovascular phenotype | 2019-03-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000180273 | SCV001924377 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001726025 | SCV001968311 | likely benign | not provided | no assertion criteria provided | clinical testing |